Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components - Wikidata - wikimedia - TriplyDB

Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components

Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components

http://www.wikidata.org/entity/Q28585466

about

Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia Neuronal migration abnormalities and its possible implications for schizophrenia Synaptic plasticity, neural circuits, and the emerging role of altered short-term information processing in schizophrenia.Neuregulin 1 Type II-ErbB Signaling Promotes Cell Divisions Generating Neurons from Neural Progenitor Cells in the Developing Zebrafish Brain Phenotypic characterization of transgenic mice overexpressing neuregulin-1 Gene × Environment Interactions in Schizophrenia: Evidence from Genetic Mouse Models Common mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disorders Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway Molecular mechanism for age-related memory loss: the histone-binding protein RbAp48 Schizophrenia is associated with dysregulation of a Cdk5 activator that regulates synaptic protein expression and cognition.Arachidonic acid drives postnatal neurogenesis and elicits a beneficial effect on prepulse inhibition, a biological trait of psychiatric illnesses Intramembranous valine linked to schizophrenia is required for neuregulin 1 regulation of the morphological development of cortical neurons Expression of the neuregulin receptor ErbB4 in the brain of the rhesus monkey (Macaca mulatta)Impaired long-term memory retention and working memory in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia Neuregulin 1 Prevents Phencyclidine-Induced Behavioral Impairments and Disruptions to GABAergic Signaling in Mice Dendritic spine pathology in neuropsychiatric disorders Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications.Partial genetic deletion of neuregulin 1 modulates the effects of stress on sensorimotor gating, dendritic morphology, and HPA axis activity in adolescent mice.Neurobehavioral Differences Between Mice Receiving Distinct Neuregulin Variants as Neonates; Impact on Sensitivity to MK-801.Neurodevelopmental animal models of schizophrenia: role in novel drug discovery and development Chronic nicotine improves short-term memory selectively in a G72 mouse model of schizophrenia.Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models.Developmental vulnerability of synapses and circuits associated with neuropsychiatric disorders.Prenatal infection and schizophrenia: a review of epidemiologic and translational studies.Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders.Sex-specific neuroendocrine and behavioral phenotypes in hypomorphic Type II Neuregulin 1 rats.The importance of the NRG-1/ErbB4 pathway for synaptic plasticity and behaviors associated with psychiatric disorders Disrupted activity in the hippocampal-accumbens circuit of type III neuregulin 1 mutant mice Review of pathological hallmarks of schizophrenia: comparison of genetic models with patients and nongenetic models Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects Prepulse inhibition and genetic mouse models of schizophrenia.Neuregulin 1 transgenic mice display reduced mismatch negativity, contextual fear conditioning and social interactions.Mice lacking the kf-1 gene exhibit increased anxiety- but not despair-like behavior.Targeted deletion of the C-terminus of the mouse adenomatous polyposis coli tumor suppressor results in neurologic phenotypes related to schizophrenia.Distinct phenotypes of new transmembrane-domain neuregulin 1 mutant mice and the rescue effects of valproate on the observed schizophrenia-related cognitive deficits A negative feedback loop controls NMDA receptor function in cortical interneurons via neuregulin 2/ErbB4 signalling.Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders.Ablation of neuropsin-neuregulin 1 signaling imbalances ErbB4 inhibitory networks and disrupts hippocampal gamma oscillation Cognition in mouse models of schizophrenia susceptibility genes.

P2860

Q24632939-719F3CEF-C801-484C-9DB8-FEDB2E51EC1C Q26824953-6E71A7E4-038E-487F-9C6A-34F152730B79 Q26829347-7B1F489D-F75B-42A3-900B-414EF7B594AF Q27306719-BCEBD8D9-3C84-42AC-AB70-53584BD0FE6E Q27316077-1836AC83-4B2D-4FFC-B36E-3421700A126D Q28067507-6F75A572-1677-49E8-B0C0-1D5A4961EB9E Q28086869-C7D7E528-F241-4114-BADE-9E198A277C38 Q28285114-49821AC5-CAB3-4891-B3FD-ADB0858FBAF8 Q28297520-BA87BD95-D652-48EF-80C6-4F477D1EFC6F Q28391148-066B93FC-A229-4E5C-8696-4BAC190DD2FC Q28475266-B56AE505-2123-4C87-8732-9873812504B9 Q28589393-9E6EC7F8-6C32-4114-B6C5-A55E4FE6914F Q28743017-8954706B-A26A-43F5-9EE9-5BE030B268E3 Q28756538-8BF0967D-0108-45DA-95BF-98836E7E94C7 Q29541297-0FAA8DEA-9B47-46E9-A6DA-3271E4D0700C Q29615871-1083DC2F-CC71-4874-B3EC-0C5F17ADBAB0 Q30387014-DD8BACC9-7493-4822-9168-4A832830B76B Q30400033-D47DCFE1-03D6-49C5-AA15-921B4E29EC75 Q30408611-CB3017EC-459E-4BF1-AEB6-D3925870888B Q30414108-CAD5D705-D391-4805-BFED-BF2617521E3E Q30415168-CA5C9256-C40E-4E61-9896-ADA19190D3A8 Q30416883-5DF01ABF-B313-4967-A93C-C5CC37414CE2 Q30435763-95495978-A708-4297-8B26-D504DDDBBE8D Q30454666-5AD935F1-2CAD-4DB3-95FE-3C4FF3688047 Q30458926-68BCFF55-1C1F-4159-80AF-25A02A84E538 Q30459497-0A444BCE-5830-4B4A-9C9D-BB69ED0680CE Q30462028-81D112E3-3583-4B8C-9012-64E336913B77 Q30464424-7025FAC9-B412-40E6-B685-C526D61274B0 Q30474983-176DB48D-E65A-4C45-A0A1-97F74CE3834A Q30476810-39F826FE-323B-4EF5-835F-4341B2DC9E5A Q30476813-EED1CB8B-D247-4BAC-9CA0-59406689014C Q30478270-2EDA6C1B-9A55-4A4F-B471-6365AA2F04F8 Q30479085-9F04FE05-86D3-41FF-AB5A-12517500E5B4 Q30492925-544471A8-3388-44A5-A8C8-EE14AAA90066 Q30576089-FD84BE2A-F094-4917-B6F7-DBCB1349DFB4 Q30576705-0A1DE812-8BEE-47D3-9241-78A8C579EAE7 Q30652639-F7EEB936-7AF1-4896-810E-87E0ED054700 Q33555684-844E689C-6E96-4FC8-A006-3EC0E2755607 Q33635538-14C00703-889E-4810-A149-CED94C23223C Q33707698-361BB3F7-7B3C-4943-87E5-DB0A5A3ED8CE

P2860

Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components

http://www.wikidata.org/entity/Q28585466

description

2008 nî lūn-bûn

@nan

2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Type III neuregulin-1 is requi ...... icostriatal circuit components

@ast

Type III neuregulin-1 is requi ...... icostriatal circuit components

@en

Type III neuregulin-1 is requi ...... icostriatal circuit components

@nl

type

label

Type III neuregulin-1 is requi ...... icostriatal circuit components

@ast

Type III neuregulin-1 is requi ...... icostriatal circuit components

@en

Type III neuregulin-1 is requi ...... icostriatal circuit components

@nl

prefLabel

Type III neuregulin-1 is requi ...... icostriatal circuit components

@ast

Type III neuregulin-1 is requi ...... icostriatal circuit components

@en

Type III neuregulin-1 is requi ...... icostriatal circuit components

@nl

P1433

Q28585466-9D4318C4-D55F-4864-BCE2-F15EC3CC9F89

P1476

Q28585466-6D9CD012-1B0A-4F71-A94A-4ADE990E0F6A

P2093

Q28585466-0066AACA-C04A-4DE2-8B87-9A2516B15044

Q28585466-228DF1DA-88ED-4631-9D75-5546205F0FA2

Q28585466-2EEE7B69-43E2-40D7-B30F-C9E5F37C11E1

Q28585466-4C052BA5-CE90-44A0-B292-D301384E9227

Q28585466-4DC9A177-345C-4D84-BBC4-8A5AF4DB752A

Q28585466-608FC8B6-B810-4A53-B6D1-E4FDCA60CEF6

Q28585466-7745C68C-8A9A-47BA-8E0D-594198291969

Q28585466-77F5AF81-6472-4BA4-A717-17912F81445B

Q28585466-89669460-8E7F-4CC5-BA5C-F2F3B08ED32B

Q28585466-8A1EC4D3-2182-4D4F-AFBC-A7853B632740

P2860

Q28585466-016C30A5-E38D-4508-BC80-0D813473E953

Q28585466-0341A405-3519-4981-800E-CACD1DC96AE3

Q28585466-03F4DD31-7531-4F6A-A36E-5EE44F8A4DC9

Q28585466-07933F28-D89E-408B-83C9-1F8E3801CF5B

Q28585466-09D927AB-8720-4B74-BC1A-F02697363805

Q28585466-0C10D692-8CA3-4060-902F-EAB557DD7126

Q28585466-1202FE3D-CD87-43B0-8061-5804E6870CF5

Q28585466-136BE283-43C1-4155-BE8A-3BE357DFD8D1

Q28585466-1759A143-8F41-4C5B-8BBC-27094A74CEDE

Q28585466-1B0EFFC6-EED7-4828-9B70-E9E1A1EC36E6

P304

Q28585466-FDAAE89D-3B95-42AB-AB5A-DF0A5C82E34F

P31

Q28585466-EE17EC63-B7E0-49E2-BC37-BA89694A7B76

P3181

Q28585466-7A407FA9-F15E-44FB-80FC-1469D432EADA

P356

Q28585466-9A73C337-2119-4356-8CEF-7C6BA2EDF834

P407

Q28585466-08222465-03C7-4232-9B27-72F2FA6755F1

P433

Q28585466-5C571C37-FE44-4D3D-93BC-E7BDC97E5BFB

P478

Q28585466-EBF20654-4307-40F6-8068-BAE11A2A6C4D

P50

Q28585466-11BBDF81-634D-4EF4-A083-3599AA33A5D4

Q28585466-638E9475-504F-4019-BB13-CCDF6050F329

P577

Q28585466-601EF3C6-0DE6-4FB6-B94A-EA4D79771E40

P698

Q28585466-04BD5FA3-4843-4820-A2B5-6C1C4B4177BD

P932

Q28585466-FFDA370F-1A47-47A4-9B10-EFE0CA0B980B

P3181

P356

JNEUROSCI.1815-08.2008

P1433

Journal of Neuroscience

P1476

Type III neuregulin-1 is requi ...... icostriatal circuit components

@en

P2093

Andrew J Dwork

http://www.w3.org/2001/XMLSchema#string

Gorazd Rosoklija

http://www.w3.org/2001/XMLSchema#string

Holly Moore

http://www.w3.org/2001/XMLSchema#string

Jay A Gingrich

http://www.w3.org/2001/XMLSchema#string

Madeleine A Johnson

http://www.w3.org/2001/XMLSchema#string

Michael D Lieberman

http://www.w3.org/2001/XMLSchema#string

Nicole Lewandowski

http://www.w3.org/2001/XMLSchema#string

Rose E Goodchild

http://www.w3.org/2001/XMLSchema#string

Ruei-Che Liu

http://www.w3.org/2001/XMLSchema#string

Scott Schobel

http://www.w3.org/2001/XMLSchema#string

P2860

Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia

Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease

Neuregulin 1 and susceptibility to schizophrenia.

Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

Nicotine use in schizophrenia: the self medication hypotheses

Multiple novel transcription initiation sites for NRG1

Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology

Axonal neuregulin-1 regulates myelin sheath thickness

P304

6872-6883

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3434062

http://www.w3.org/2001/XMLSchema#string

P356

10.1523/JNEUROSCI.1815-08.2008

http://www.w3.org/2001/XMLSchema#string

P407

P433

27

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18596162

http://www.w3.org/2001/XMLSchema#string

P932

2728592

http://www.w3.org/2001/XMLSchema#string